Ident. | Authors (with country if any) | Title |
---|
000418 (2020) |
Bhasker Amatya [Australie] ; Fary Khan ; Imogen Windle ; Matthew Lowe ; Mary P. Galea | Evaluation of a technology-assisted enriched environmental activities programme for upper limb function: A randomized controlled trial. |
000484 (2020) |
Andrew M. Chanen [Australie] ; Katie Nicol [Australie] ; Jennifer K. Betts [Australie] ; Katherine N. Thompson [Australie] | Diagnosis and Treatment of Borderline Personality Disorder in Young People. |
000620 (2019) |
Melissa Bardell-Williams [Australie] ; Scott Eaton [Australie] ; Linglee Downey [Australie] ; Meghan Bowtell [Australie] ; Kristen Thien [Australie] ; Aswin Ratheesh [Australie] ; Eoin Killackey [Australie] ; Patrick Mcgorry [Australie] ; Brian O'Donoghue [Australie] | Rates, determinants and outcomes associated with the use of community treatment orders in young people experiencing first episode psychosis. |
000621 (2019) |
Ashley M. Hopkins [Australie] ; Ganessan Kichenadasse [Australie] ; Ross A. Mckinnon [Australie] ; Andrew Rowland [Australie] ; Michael J. Sorich [Australie] | Baseline tumor size and survival outcomes in lung cancer patients treated with immune checkpoint inhibitors. |
000671 (2019) |
Da Jung Kim [Australie] ; Ellie Brown [Australie] ; Siobhan Reynolds [Australie] ; Hellen Geros [Australie] ; Holly Sizer [Australie] ; Rachel Tindall [Australie] ; Patrick Mcgorry [Australie] ; Brian O'Donoghue [Australie] | The rates and determinants of disengagement and subsequent re-engagement in young people with first-episode psychosis. |
000700 (2019) |
Melissa Pyle [Royaume-Uni] ; Matthew R. Broome [Royaume-Uni] ; Emmeline Joyce [Royaume-Uni] ; Graeme Maclennan [Royaume-Uni] ; John Norrie [Royaume-Uni] ; Daniel Freeman [Royaume-Uni] ; David Fowler [Royaume-Uni] ; Peter M. Haddad [Royaume-Uni, Qatar] ; David Shiers [Royaume-Uni] ; Chris Hollis [Royaume-Uni] ; Jo Smith [Royaume-Uni] ; Ashley Liew [Royaume-Uni] ; Rory E. Byrne [Royaume-Uni] ; Paul French [Royaume-Uni] ; Sarah Peters [Royaume-Uni] ; Jemma Hudson [Royaume-Uni] ; Linda Davies [Royaume-Uni] ; Richard Emsley [Royaume-Uni] ; Alison Yung [Royaume-Uni, Australie] ; Max Birchwood [Royaume-Uni] ; Eleanor Longden [Royaume-Uni] ; Anthony P. Morrison [Royaume-Uni] | Study protocol for a randomised controlled trial of CBT vs antipsychotics vs both in 14-18-year-olds: Managing Adolescent first episode Psychosis: a feasibility study (MAPS). |
000734 (2019) |
David Sands Johnson [Royaume-Uni] ; Philip Gartside Turner [Royaume-Uni] | Replacement for patellofemoral arthritis. |
000A05 (2019) |
Karl Andriessen [Australie] ; Karolina Krysinska [Australie] ; Nicole T M. Hill [Australie] ; Lennart Reifels [Australie] ; Jo Robinson [Australie] ; Nicola Reavley [Australie] ; Jane Pirkis [Australie] | Effectiveness of interventions for people bereaved through suicide: a systematic review of controlled studies of grief, psychosocial and suicide-related outcomes. |
000B19 (2019) |
Yu Chen [République populaire de Chine] ; Gang Chen [République populaire de Chine] ; Jin Li [République populaire de Chine] ; Ying-Ying Huang [République populaire de Chine] ; Yi Li [République populaire de Chine] ; Jing Lin [République populaire de Chine] ; Li-Zhu Chen [République populaire de Chine] ; Jian-Ping Lu [République populaire de Chine] ; Yu-Qi Wang [République populaire de Chine] ; Chang-Xi Wang [République populaire de Chine] ; Leong Kin Pan [République populaire de Chine] ; Xue-Feng Xia [République populaire de Chine] ; Xin Yi [République populaire de Chine] ; Chuan-Ben Chen [République populaire de Chine] ; Xiong-Wei Zheng [République populaire de Chine] ; Zeng-Qing Guo [République populaire de Chine] ; Jian-Ji Pan [République populaire de Chine] | Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer. |
000B63 (2019) |
Michael Berk [Australie] ; Alyna Turner [Australie] ; Gin S. Malhi [Australie] ; Chee H. Ng [Australie] ; Susan M. Cotton [Australie] ; Seetal Dodd [Australie] ; Yuval Samuni [Australie] ; Michelle Tanious [Australie] ; Claire Mcaulay [Australie] ; Nathan Dowling [Australie] ; Jerome Sarris [Australie] ; Lauren Owen [Royaume-Uni] ; Astrid Waterdrinker [Australie] ; Deidre Smith [Australie] ; Olivia M. Dean [Australie] | A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. |
000C46 (2018) |
Evan Landau [États-Unis] ; Shalom Kalnicki [États-Unis] | The Evolving Role of Radiation in Pancreatic Cancer. |
000C71 (2018) |
Kelly A. Allott [Australie] ; Hok Pan Yuen [Australie] ; Cali F. Bartholomeusz [Australie] ; Marta Rapado-Castro [Espagne] ; Christina Phassouliotis [Australie] ; Felicity Butselaar [Australie] ; Stephen J. Wood [Royaume-Uni] ; Tina-Marie Proffitt [Australie] ; Greg Savage [Australie] ; Lisa J. Phillips [Australie] ; Sarah Bendall [Australie] ; Connie Markulev [Australie] ; Renate L E P. Reniers [Royaume-Uni] ; Christos Pantelis [Australie] ; Lara Baldwin [Australie] ; Patrick D. Mcgorry [Australie] ; Belinda Garner [Australie] | Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis. |
000D22 (2018) |
Raja B. Khan [États-Unis] ; Thomas E. Merchant [États-Unis] ; Zsila S. Sadighi [États-Unis] ; Mercedes S. Bello [États-Unis] ; Zhaohua Lu [États-Unis] ; April Sykes [États-Unis] ; Merrill S. Wise [États-Unis] ; Valerie M. Crabtree [États-Unis] ; Jennifer Zabrowski [États-Unis] ; Andrea Simmons [États-Unis] ; Mary E. Clark [États-Unis] ; Belinda N. Mandrell [États-Unis] | Prevalence, risk factors, and response to treatment for hypersomnia of central origin in survivors of childhood brain tumors. |
000D25 (2018) |
Nilufar Mossaheb [Autriche] ; Miriam R. Sch Fer [Australie] ; Monika Schlögelhofer [Autriche] ; Claudia M. Klier [Autriche] ; Stefan Smesny [Allemagne] ; Patrick D. Mcgorry [Australie] ; Maximus Berger [Australie] ; G Paul Amminger [Australie] | Predictors of longer-term outcome in the Vienna omega-3 high-risk study. |
000F91 (2018) |
Kristen Thien [Australie] ; Meghan Bowtell [Australie] ; Scott Eaton [Australie] ; Melissa Bardell-Williams [Australie] ; Linglee Downey [Australie] ; Aswin Ratheesh [Australie] ; Patrick Mcgorry [Australie] ; Brian O'Donoghue [Australie] | Clozapine use in early psychosis. |
001086 (2018) |
Laurent Claret [France] ; Jin Y. Jin [États-Unis] ; Charles Ferté [France] ; Helen Winter [États-Unis] ; Sandhya Girish [États-Unis] ; Mark Stroh [États-Unis] ; Pei He [États-Unis] ; Marcus Ballinger [États-Unis] ; Alan Sandler [États-Unis] ; Amita Joshi [États-Unis] ; Achim Rittmeyer [Allemagne] ; David Gandara [États-Unis] ; Jean-Charles Soria [France] ; René Bruno [France] | A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non-Small Cell Lung Cancer Based on Early Tumor Kinetics. |
001140 (2017) |
Chana Weinstock [États-Unis] ; Sean Khozin [États-Unis] ; Daniel Suzman [États-Unis] ; Lijun Zhang [États-Unis] ; Shenghui Tang [États-Unis] ; Sakar Wahby [États-Unis] ; Kirsten B. Goldberg [États-Unis] ; Geoffrey Kim [États-Unis] ; Richard Pazdur [États-Unis] | U.S. Food and Drug Administration Approval Summary: Atezolizumab for Metastatic Non-Small Cell Lung Cancer. |
001221 (2017) |
Philippe Conus [Suisse, Australie] ; Sue Cotton [Australie] ; Benno G. Schimmelmann [Suisse, Allemagne] ; Patrick D. Mcgorry [Australie] ; Martin Lambert [Allemagne] | Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis. |
001242 (2017) |
S M Cotton [Australie] ; M. Lambert [Allemagne] ; B G Schimmelmann [Suisse] ; K. Filia [Australie] ; V. Rayner [Australie] ; L. Hides [Australie] ; D L Foley [Australie] ; A. Ratheesh [Australie] ; A. Watson [Australie] ; P. Rodger [Australie] ; P D Mcgorry [Australie] ; P. Conus [Suisse] | Predictors of functional status at service entry and discharge among young people with first episode psychosis. |
001243 (2017) |
Philippe Conus [Suisse] ; Sue M. Cotton [Australie] ; Shona M. Francey [Australie] ; Brian O'Donoghue [Australie] ; Benno G. Schimmelmann [Suisse] ; Patrick D. Mcgorry [Australie] ; Martin Lambert [Allemagne] | Predictors of favourable outcome in young people with a first episode psychosis without antipsychotic medication. |
001414 (2017) |
Stefan Smesny [Allemagne] ; Berko Milleit [Allemagne] ; Miriam R. Schaefer [Autriche] ; Jana Hesse [Allemagne] ; Monika Schlögelhofer [Autriche] ; Kerstin Langbein [Allemagne] ; Uta-Christina Hipler [Allemagne] ; Maximus Berger [Australie] ; David R. Cotter [Irlande (pays)] ; Heinrich Sauer [Allemagne] ; Patrick D. Mcgorry [Australie] ; G Paul Amminger [Autriche] | Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study. |